175 related articles for article (PubMed ID: 19056541)
1. Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues.
Lemancewicz D; Dziecioł J; Piszcz J; Lebelt A; Mazgajska-Barczyk K; Klim B; Kłoczko J
Folia Histochem Cytobiol; 2008; 46(3):361-6. PubMed ID: 19056541
[TBL] [Abstract][Full Text] [Related]
2. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia.
Wolowiec D; Wozniak Z; Potoczek S; Ganczarski G; Wrobel T; Kuliczkowski K; Frydecka I; Jeleń M
Anal Quant Cytol Histol; 2004 Oct; 26(5):263-70. PubMed ID: 15560532
[TBL] [Abstract][Full Text] [Related]
4. The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia.
Lemancewicz D; Dziecioł J; Kłoczko J; Piszcz J
Folia Morphol (Warsz); 2004 Nov; 63(4):485-9. PubMed ID: 15712148
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
6. Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission.
Oudat R; Keating MJ; Lerner S; O'Brien S; Albitar M
Leukemia; 2002 Apr; 16(4):632-5. PubMed ID: 11960343
[TBL] [Abstract][Full Text] [Related]
7. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues.
Piszcz JA; Lemancewicz D; Kloczko J; Dzieciol J; Rusak M; Dabrowska M
Exp Oncol; 2007 Sep; 29(3):221-5. PubMed ID: 18004250
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
10. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders.
Sah SP; Matutes E; Wotherspoon AC; Morilla R; Catovsky D
J Clin Pathol; 2003 Feb; 56(2):129-32. PubMed ID: 12560392
[TBL] [Abstract][Full Text] [Related]
11. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
[TBL] [Abstract][Full Text] [Related]
12. The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemia.
Capitani N; Baldari CT
Curr Med Chem; 2010; 17(9):801-11. PubMed ID: 20156175
[TBL] [Abstract][Full Text] [Related]
13. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
15. Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl G; Sahakyan K; Denk U; Girbl T; Alinger B; Hofbauer SW; Neureiter D; Hofbauer JP; Egle A; Greil R; Hartmann TN
PLoS One; 2011; 6(8):e23758. PubMed ID: 21876768
[TBL] [Abstract][Full Text] [Related]
16. FOXP1 and BCL2 show similar immunoenzymatic pattern in bone marrow trephines of chronic lymphocytic leukemia patients.
Korać P; Vintar MG; Ajduković R; Kardum Paro MM; Jaksić B; Dominis M
Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):500-4. PubMed ID: 19417623
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of ZAP-70 protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma].
Qi RJ; Zhang PH; Qiu LG; Fang LH; Yang QY; Sun FJ; Chen HS
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):329-32. PubMed ID: 19575876
[TBL] [Abstract][Full Text] [Related]
18. Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression.
Podhorecka M; Klimek P; Kowal M; Chocholska S; Bojarska-Junak A; Dmoszynska A
Acta Haematol; 2010; 123(3):171-8. PubMed ID: 20224269
[TBL] [Abstract][Full Text] [Related]
19. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
Saxena A; Viswanathan S; Moshynska O; Tandon P; Sankaran K; Sheridan DP
Am J Hematol; 2004 Jan; 75(1):22-33. PubMed ID: 14695629
[TBL] [Abstract][Full Text] [Related]
20. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.
Packham G; Stevenson FK
Immunology; 2005 Apr; 114(4):441-9. PubMed ID: 15804279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]